Hidekazu Hirano
机构：National Cancer Centre Japan, National Cancer Center, National Cancer Center Hospital East, Tokyo National Hospital · ORCID：0000-0003-1343-1419
发表论文 209 篇 · 总被引 1296 次 · h-index 15
代表论文
- Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer (2025 · Future Oncology · 被引 3)
- Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer (2026 · Targeted Oncology · 被引 1)
- Trifluridine/tipiracil with or without bevacizumab in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: A retrospective observational study (2026 · Therapeutic Advances in Medical Oncology)
- Tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the Asian subgroup of the RATIONALE-305 study (2026 · Figshare)
- Tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the Asian subgroup of the RATIONALE-305 study (2026 · Figshare)
- Gut microbiota dynamics of antibiotic fecal microbiota transplantation in esophageal and gastric cancer patients treated with immune checkpoint inhibitors: Preliminary results from the Biorich2 study. (2026 · Journal of Clinical Oncology)